Edition:
United States

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

9.99USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$9.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
160,830
52-wk High
$20.78
52-wk Low
$7.42

Select another date:

Tue, Nov 7 2017

BRIEF-Bellicum reports qtrly earnings per share loss‍ $0.71​

* Bellicum Pharmaceuticals Inc qtrly earnings per share loss‍ $0.71​

BRIEF-Bellicum Pharmaceuticals enters a cancer research grant contract with cancer prevention and research institute of Texas

* Bellicum Pharmaceuticals says ‍on Aug. 9, entered a cancer research grant contract with cancer prevention and research institute of Texas

BRIEF-Bellicum Pharmaceuticals qtrly loss per share $0.74

* Bellicum pharmaceuticals reports second quarter 2017 financial results and provides corporate update

BRIEF-Bellicum Pharmaceuticals files for mixed shelf offering of upto $150 mln

* Bellicum Pharmaceuticals Inc files for mixed shelf offering of upto $150 million - sec filing Source text: (http://bit.ly/2tmwwmp) Further company coverage:

BRIEF-Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares

* Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares of co's common stock held by the selling stockholders

Select another date: